The U.S. defense industry is entering a period of significant growth. The National Defense Authorization Act (NDAA) is estimated at $961 billion between the Department of War and the Department of Energy.
For decades, Boston has been a global engine for innovation in healthcare and biotechnology. The city has received more National Institutes of Health (NIH) funding than any other over the last 20 years, and is home to one of the highest concentrations of life sciences investment in the world.
The topic of reshoring manufacturing to the United States continues to gain traction, especially with the introduction of costly tariffs earlier this year.